IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,942,304 | -13.4% | 576,923 | 0.0% | 35.70% | +29.7% |
| Q2 2023 | $34,592,303 | +21.3% | 576,923 | 0.0% | 27.53% | +9.3% |
| Q1 2023 | $28,523,073 | -13.4% | 576,923 | 0.0% | 25.19% | -0.7% |
| Q4 2022 | $32,924,996 | +21.5% | 576,923 | 0.0% | 25.37% | +18.4% |
| Q3 2022 | $27,100,000 | +26.0% | 576,923 | 0.0% | 21.42% | +29.6% |
| Q2 2022 | $21,500,000 | +25.0% | 576,923 | 0.0% | 16.53% | +78.7% |
| Q1 2022 | $17,200,000 | -69.2% | 576,923 | 0.0% | 9.25% | -45.4% |
| Q4 2021 | $55,800,000 | +160.7% | 576,923 | 0.0% | 16.93% | +170.2% |
| Q3 2021 | $21,400,000 | -7.0% | 576,923 | 0.0% | 6.26% | +77.3% |
| Q2 2021 | $23,000,000 | -6.4% | 576,923 | 0.0% | 3.53% | -12.1% |
| Q1 2021 | $24,560,000 | – | 576,923 | – | 4.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |